Drug interactions between Levaquin and tigecycline
Interactions between your drugs
There were no interactions found in our database between Levaquin and tigecycline - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Levaquin is in the drug class quinolones.
- Levaquin is used to treat the following conditions:
- Anthrax Prophylaxis
- Bacterial Infection
- Bladder Infection
- Chlamydia Infection
- Epididymitis, Sexually Transmitted
- Gonococcal Infection, Disseminated
- Gonococcal Infection, Uncomplicated
- Kidney Infections
- Nongonococcal Urethritis
- Nosocomial Pneumonia
- Otitis Media
- Pelvic Inflammatory Disease
- Plague Prophylaxis
- Skin or Soft Tissue Infection
- Streptococcal Infection
- Tuberculosis, Active
- Urinary Tract Infection
- Tigecycline is a member of the drug class glycylcyclines.
- Tigecycline is used to treat the following conditions:
Drug and food interactions
Applies to: Levaquin (levofloxacin)
When levoFLOXacin as the oral solution is given with enteral (tube) feedings, levoFLOXacin may not work as well. You could interrupt the feeding for 1 hour before and 2 hours after the levoFLOXacin dose. However, this still may not entirely avoid the interaction and may not always be feasible. LevoFLOXacin oral tablets may be taken without regard to food. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|